Management of the antiphospholipid syndromeKHAMASHTA, M. A; WALLINGTON, T.Annals of the rheumatic diseases. 1991, Vol 50, Num 12, pp 959-962, issn 0003-4967Article

Anticardiolipin antibodyHUGHES, G. R. V; KHAMASHTA, M. A.British medical journal (1857). 1989, Vol 299, Num 6713, pp 1414-1415, issn 0007-1447, 2 p.Article

Stroke and antiphospholipid syndrome : the treatment debateRUIZ-IRASTORZA, G; KHAMASHTA, M. A.Rheumatology (Oxford. Print). 2005, Vol 44, Num 8, pp 971-974, issn 1462-0324, 4 p.Article

Seronegative antiphospholipid syndromeHUGHES, G. R. V; KHAMASHTA, M. A.Annals of the rheumatic diseases. 2003, Vol 62, Num 12, issn 0003-4967, p. 1127Article

Systemischer Lupus erythematodes und Antiphospholipidsyndrome in der Schwangerschaft : Rheumatische Erkrankungen in der Schwangerschaft = Systematic lupus erythematosus and antiphospholipid syndrome during pregnancyRUIZ-IRASTORZA, G; KHAMASHTA, M. A.Zeitschrift für Rheumatologie (Print). 2006, Vol 65, Num 3, issn 0340-1855, 192-199 [7 p.]Article

The antiphospholipid syndromeHUGHES, G. R. V; KHAMASHTA, M. A.Journal of the Royal College of Physicians of London. 1994, Vol 28, Num 4, pp 301-304, issn 0035-8819Article

Detection and importance of anticardiolipin antibodiesKHAMASHTA, M. A; HUGHES, G. R. V.Journal of clinical pathology. 1993, Vol 46, Num 2, pp 104-107, issn 0021-9746Article

Splenectomy for refractory thrombocytopenia in the antiphospholipid syndromeGALINDO, M; KHAMASHTA, M. A; HUGHES, G. R. V et al.Rheumatology (Oxford. Print). 1999, Vol 38, Num 9, pp 848-853, issn 1462-0324Article

Overlap syndromesCERVERA, R; KHAMASHTA, M. A; HUGHES, G. R. V et al.Annals of the rheumatic diseases. 1990, Vol 49, Num 11, pp 947-948, issn 0003-4967, 2 p.Article

Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndromeCONTI, F; ALESSANDRI, C; VALESINI, G et al.Clinical and experimental immunology (Print). 2012, Vol 167, Num 3, pp 429-437, issn 0009-9104, 9 p.Article

Treatment of mesenteric angina with prolonged anticoagulation in a patient with antiphospholipid (Hughes) syndrome and coeliac artery stenosisROSENTHAL, E; SANGLE, S. R; TAYLOR, P et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 10, pp 1398-1399, issn 0003-4967, 2 p.Article

Prevalence of the antiphospholipid syndrome in primary systemic vasculitisREES, J. D; LANCA, S; MARQUES, P. V et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 1, pp 109-111, issn 0003-4967, 3 p.Article

The placental bed in pregnancies complicated by primary antiphospholipid syndromeSTONE, S; PIJNENBORG, R; VERCRUYSSE, L et al.Placenta (Eastbourne). 2006, Vol 27, Num 4-5, pp 457-467, issn 0143-4004, 11 p.Article

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathyKARIM, M. Y; PISONI, C. N; FERRO, L et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 10, pp 1317-1321, issn 1462-0324, 5 p.Article

Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fracturesSANGLE, S; D'CRUZ, D. P; KHAMASHTA, M. A et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 10, pp 1241-1243, issn 0003-4967, 3 p.Article

Value of IgA anticardiolipin and anti-β₂-glycoprotein I antibody testing in patients with pregnancy morbidityCARMO-PEREIRA, S; BERTOLACCINI, M. L; ESCUDERO-CONTRERAS, A et al.Annals of the rheumatic diseases. 2003, Vol 62, Num 6, pp 540-543, issn 0003-4967, 4 p.Article

Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndromeSHOENFELD, Y; KRAUSE, I; BOFFA, M. C et al.Journal of clinical immunology. 2003, Vol 23, Num 5, pp 377-383, issn 0271-9142, 7 p.Article

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agentsKARIM, M. Y; ALBA, P; CUADRADO, M.-J et al.Rheumatology (Oxford. Print). 2002, Vol 41, Num 8, pp 876-882, issn 1462-0324Article

Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate : a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patientsGODFREY, T; CUADRADO, M. J; FOFI, C et al.Rheumatology (Oxford. Print). 2001, Vol 40, Num 3, pp 324-328, issn 1462-0324Article

Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus : evidence of a shared pathogenesisMILLARD, T. P; LEWIS, C. M; KHAMASHTA, M. A et al.British journal of dermatology (1951). 2001, Vol 144, Num 2, pp 334-338, issn 0007-0963Article

The anti-phospholipid antibody syndrome (Hughes syndrome) : therapeutic aspectsCUADRADC, M. J; KHAMASHTA, M. A.Baillière's best practice & research. Clinical rheumatology. 2000, Vol 14, Num 1, pp 151-163, issn 1521-6942Article

Correlation between β2-glycoprotein I valine/leucine²⁴⁷ polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndromeATSUMI, T; TSUTSUMI, A; AMENGUAL, O et al.Rheumatology (Oxford. Print). 1999, Vol 38, Num 8, pp 721-723, issn 1462-0324Conference Paper

Binding of anticardiolipin antibodies to protein C via β₂-glycoprotein I (β₂-GPI) : a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C systemATSUMI, T; KHAMASHTA, M. A; AMENGUAL, O et al.Clinical and experimental immunology (Print). 1998, Vol 112, Num 2, pp 325-333, issn 0009-9104Article

Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndromeATSUMI, T; KHAMASHTA, M. A; ANDUJAR, C et al.Journal of rheumatology. 1998, Vol 25, Num 1, pp 69-73, issn 0315-162XArticle

Fcγ receptor IIA H/R131 polymorphism in patients with antiphospholipid antibodiesATSUMI, T; CALIZ, R; AMENGUAL, O et al.Thrombosis and haemostasis. 1998, Vol 79, Num 5, pp 924-927, issn 0340-6245Article